Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,971 | 440 | 81.5% |
| Education | $1,119 | 27 | 10.2% |
| Travel and Lodging | $923.36 | 4 | 8.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,503 | 75 | $0 (2024) |
| Medtronic USA, Inc. | $1,003 | 9 | $0 (2019) |
| Janssen Biotech, Inc. | $915.07 | 49 | $0 (2024) |
| COLOPLAST CORP | $828.65 | 27 | $0 (2021) |
| ABBVIE INC. | $812.88 | 45 | $0 (2024) |
| C. R. Bard, Inc. & Subsidiaries | $764.80 | 17 | $0 (2024) |
| PFIZER INC. | $480.52 | 29 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $414.03 | 26 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $370.01 | 19 | $0 (2024) |
| Amgen Inc. | $368.29 | 22 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,409 | 46 | C. R. Bard, Inc. & Subsidiaries ($416.06) |
| 2023 | $1,033 | 40 | C. R. Bard, Inc. & Subsidiaries ($317.95) |
| 2022 | $720.97 | 33 | Astellas Pharma US Inc ($126.47) |
| 2021 | $748.32 | 44 | Astellas Pharma US Inc ($137.47) |
| 2020 | $675.15 | 30 | Coloplast Corp ($271.46) |
| 2019 | $2,554 | 97 | Medtronic USA, Inc. ($1,003) |
| 2018 | $1,938 | 90 | Astellas Pharma US Inc ($480.77) |
| 2017 | $1,935 | 91 | KARL STORZ Endoscopy-America ($313.71) |
All Payment Transactions
471 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Urology | ||||||
| 12/13/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: UROTHELIAL CANCER | ||||||
| 11/14/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/30/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $28.42 | General |
| Category: Oncology | ||||||
| 10/18/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: UROLOGY | ||||||
| 10/04/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: UROLOGY | ||||||
| 10/03/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $29.62 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 09/18/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: HORMONE THERAPY | ||||||
| 09/10/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: ONCOLOGY | ||||||
| 09/04/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $29.07 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 08/30/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: ONCOLOGY | ||||||
| 08/06/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $33.54 | General |
| Category: Oncology | ||||||
| 08/05/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $77.97 | General |
| 08/02/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: Oncology | ||||||
| 08/01/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: HORMONE THERAPY | ||||||
| 07/31/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: Urology | ||||||
| 07/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Oncology | ||||||
| 06/21/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: ONCOLOGY | ||||||
| 06/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: UROLOGY | ||||||
| 06/12/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/08/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Oncology | ||||||
| 05/31/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $24.42 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,897 | 12,030 | $819,417 | $242,596 |
| 2022 | 34 | 3,274 | 9,773 | $887,829 | $272,508 |
| 2021 | 33 | 3,324 | 10,111 | $968,632 | $289,555 |
| 2020 | 33 | 3,314 | 10,543 | $932,801 | $275,180 |
All Medicare Procedures & Services
132 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 671 | 904 | $180,800 | $59,160 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 276 | 362 | $90,500 | $36,640 | 40.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 26 | 194 | $96,030 | $25,575 | 26.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 21 | 4,400 | $74,800 | $21,840 | 29.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 65 | 99 | $49,500 | $19,299 | 39.0% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Office | 2023 | 20 | 32 | $27,200 | $10,461 | 38.5% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 48 | 191 | $35,335 | $9,598 | 27.2% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 170 | 196 | $34,300 | $9,356 | 27.3% |
| 52648 | Complete laser vaporization of prostate including control of bleeding using an endoscope | Facility | 2023 | 11 | 11 | $41,250 | $6,092 | 14.8% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 28 | 82 | $14,350 | $5,115 | 35.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 425 | 571 | $28,550 | $4,950 | 17.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $11,020 | $4,795 | 43.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 28 | $8,400 | $3,989 | 47.5% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Facility | 2023 | 17 | 28 | $23,800 | $3,822 | 16.1% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 11 | 1,709 | $20,508 | $3,767 | 18.4% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 12 | 46 | $9,430 | $3,375 | 35.8% |
| 52235 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | Facility | 2023 | 13 | 13 | $9,425 | $2,998 | 31.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 16 | $10,400 | $2,294 | 22.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 676 | 1,033 | $25,825 | $2,264 | 8.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 22 | 28 | $5,600 | $1,780 | 31.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 150 | 187 | $4,675 | $1,563 | 33.4% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 24 | 48 | $3,600 | $1,300 | 36.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 123 | $7,380 | $1,264 | 17.1% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 18 | 18 | $3,150 | $505.36 | 16.0% |
| J1020 | Injection, methylprednisolone acetate, 20 mg | Office | 2023 | 21 | 111 | $777.00 | $436.10 | 56.1% |
About Sagar Phatak, M. D
Sagar Phatak, M. D is a Urology healthcare provider based in Middlebury, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023033149.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sagar Phatak, M. D has received a total of $11,014 in payments from pharmaceutical and medical device companies, with $1,409 received in 2024. These payments were reported across 471 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($8,971).
As a Medicare-enrolled provider, Phatak has provided services to 12,809 Medicare beneficiaries, totaling 42,457 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 132 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Middlebury, CT
- Active Since 07/12/2006
- Last Updated 07/09/2007
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1023033149
Products in Payments
- INTERSTIM (Device) $1,145
- XTANDI (Drug) $939.98
- Bard Urinary Drainage Bag (Device) $734.01
- SPEEDICATH (Device) $507.59
- Natesto (Drug) $435.17
- XIAFLEX (Biological) $414.02
- ZYTIGA (Drug) $328.26
- Lupron (Drug) $323.42
- Prolia (Biological) $322.49
- ERLEADA (Drug) $321.83
- TELESCOPE,HOPKINS,6',AUTOCLAV, (Device) $313.71
- Erleada (Drug) $264.98
- PROVENGE (Drug) $257.40
- ELIGARD (Drug) $208.05
- MYRBETRIQ (Drug) $203.94
- GEMTESA (Drug) $196.76
- CONTINENCE CARE (Device) $195.90
- Xofigo (Drug) $192.90
- Androgel (Drug) $190.25
- Nubeqa (Drug) $177.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Middlebury
York Moy, M.d, M.D
Urology — Payments: $19,679
Anthony Kim, M. D, M. D
Urology — Payments: $14,108
Michael Flanagan, M.d, M.D
Urology — Payments: $8,362
Joseph Antoci, M. D, M. D
Urology — Payments: $100.28
Robert Feldman, M.d, M.D
Urology — Payments: $83.85